• LAST PRICE
    1.6500
  • TODAY'S CHANGE (%)
    Trending Down-0.0300 (-1.7857%)
  • Bid / Lots
    1.6200/ 12
  • Ask / Lots
    1.6500/ 178
  • Open / Previous Close
    1.6600 / 1.6800
  • Day Range
    Low 1.6500
    High 1.7100
  • 52 Week Range
    Low 1.5000
    High 4.5800
  • Volume
    53,442
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 1.68
TimeVolumeOCUP
09:32 ET13321.6501
09:36 ET1901.6593
09:39 ET6001.6681
09:41 ET18941.7
09:45 ET8001.69
09:50 ET3001.69
09:59 ET1091.69
10:06 ET2001.68
10:12 ET46001.66
10:17 ET1481.6506
10:35 ET10001.65
10:37 ET12001.67
10:39 ET2001.67
10:53 ET1001.67
11:00 ET1001.68
11:02 ET3001.68
11:15 ET1001.69
11:18 ET8501.68
11:20 ET2001.69
11:26 ET14001.66
11:42 ET1001.67
11:44 ET2251.67
11:54 ET6001.68
11:58 ET14911.6769
12:09 ET4861.6714
12:14 ET8551.68
12:36 ET28291.68
12:43 ET1001.67
12:50 ET1001.68
12:52 ET5501.67
12:54 ET4501.6601
12:56 ET4501.6601
01:08 ET1101.66
01:10 ET1931.665
01:12 ET5001.6646
01:28 ET6331.66
01:46 ET3001.67
01:50 ET2001.67
01:57 ET1481.66
02:11 ET1001.66
02:18 ET1001.67
02:29 ET13001.67
02:49 ET1001.66
02:54 ET3901.67
02:58 ET1001.665
03:00 ET2201.6663
03:12 ET2001.665
03:20 ET6001.66
03:32 ET7501.6687
03:38 ET6001.67
03:50 ET2711.66
03:54 ET69451.65
03:56 ET67041.65
03:59 ET15881.65
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesOCUP
Ocuphire Pharma Inc
42.8M
-3.4x
---
United StatesRPID
Rapid Micro Biosystems Inc
33.0M
-0.6x
---
United StatesEVFM
Evofem Biosciences Inc
806.8K
0.0x
---
United StatesCVSI
CV Sciences Inc
13.6M
-4.0x
-25.43%
United StatesUG
United-Guardian Inc
41.3M
15.0x
-9.92%
United StatesCYAN
Cyanotech Corp
2.1M
-0.4x
---
As of 2024-06-17

Company Information

Ocuphire Pharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. The Company’s lead retinal product candidate, APX3330, is a small-molecule inhibitor of Ref-1 (reduction oxidation effector factor-1 protein). Ref1 is a regulator of transcription factors such as HIF-1α and NF-B. The Inhibiting REF-1 reduces levels of vascular endothelial growth factor (VEGF) and inflammatory cytokines which are known to play key roles in ocular angiogenesis and inflammation. APX3330 is an oral tablet to be administered twice per day for the treatment of DR. The Company’s pipeline candidates include APX2009 and APX2014. The Company is initially pursuing APX3330 for the DR indication as first-line therapy and may explore opportunities for clinical benefit as monotherapy or adjunctive therapy for other retinal indications such as DME, wAMD, and GA.

Contact Information

Headquarters
37000 Grand River Ave., Suite 120FARMINGTON HILLS, MI, United States 48335
Phone
248-681-9815
Fax
240-268-5310

Executives

Independent Chairman of the Board
Cam Gallagher
Chief Executive Officer, Director
George Magrath
Chief Financial Officer, Principal Financial Officer
Nirav Jhaveri
Chief Operating Officer
Joseph Schachle
Senior Vice President - Corporate Development and Operations
Bernhard Hoffmann

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$42.8M
Revenue (TTM)
$19.0M
Shares Outstanding
25.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.33
EPS
$-0.49
Book Value
$2.08
P/E Ratio
-3.4x
Price/Sales (TTM)
2.3
Price/Cash Flow (TTM)
---
Operating Margin
-63.86%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.